These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The use of mucolytic preparations (Mucosolvan) in nasal and paranasal sinuses in children].
    Author: Golusiński W, Szmeja Z, Szyfter W, Kruk-Zagajewska A, Mielcarek-Kuchta D, Laczkowska-Przybylska J.
    Journal: Otolaryngol Pol; 1996; 50(6):599-606. PubMed ID: 9173390.
    Abstract:
    In recent years there has been observed an increase in the infections of nose cavity and paranasal sinuses. This phenomenon is connected with a multidirectional alergization of the environment also with the insufficiency of conservative and surgical treatment. Messerklinger's research concerning cilial movements of mucosa in nasal and paranasal sinuses together with his endoscopic experiments are the basic for modern therapy of nasal and paranasal sinuses. In this paper 40 cases of acute and chronic inflammation of paranasal sinuses in children between 3 and 16 years of age were presented. In all cases regardless of the used method of conservative or surgical treatment children were given mucolytic preparations in the form of Mucosolvan by Boehringer Ingelheim. In all observed cases we noticed the shortening of the normal period of the antiinflammatory antibiotic treatment. A part from that, mucolitic preparations due to the decrease of mucous adhesiveness to the walls of paranasal sinuses allow for its evacuation largely decreasing the pain. After FESS treatment, the administration mucolytic preparations causes a factor regeneration of cilial epithelium, proper functioning of cilia and the speeding of mucocilial trnasport, which makes the recovery of an ill child much quicker.
    [Abstract] [Full Text] [Related] [New Search]